These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 33103587)

  • 1. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway.
    Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L
    RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
    Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
    Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTO-Dependent N
    Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
    Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
    Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
    Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.
    Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F
    J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fat mass and obesity associated (FTO)-mediated N6-methyladenosine modification of Kr├╝ppel-like factor 3 (KLF3) promotes osteosarcoma progression.
    Shan HJ; Gu WX; Duan G; Chen HL
    Bioengineered; 2022 Apr; 13(4):8038-8050. PubMed ID: 35311620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HOXB13 promotes gastric cancer cell migration and invasion via IGF-1R upregulation and subsequent activation of PI3K/AKT/mTOR signaling pathway.
    Guo C; Chu H; Gong Z; Zhang B; Li C; Chen J; Huang L
    Life Sci; 2021 Aug; 278():119522. PubMed ID: 33894267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
    Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
    J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel positioning from obesity to cancer: FTO, an m
    Chen J; Du B
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):19-29. PubMed ID: 30465076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients.
    Yi W; Yu Y; Li Y; Yang J; Gao S; Xu L
    Bioengineered; 2021 Dec; 12(1):5323-5333. PubMed ID: 34499008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTO up-regulation induced by MYC suppresses tumour progression in Epstein-Barr virus-associated gastric cancer.
    Xu YY; Li T; Shen A; Bao XQ; Lin JF; Guo LZ; Meng Q; Ruan DY; Zhang QH; Zuo ZX; Zeng ZL
    Clin Transl Med; 2023 Dec; 13(12):e1505. PubMed ID: 38082402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTO facilitates cancer metastasis by modifying the m
    Gao L; Wang A; Chen Y; Cai X; Li Y; Zhao J; Zhang Y; Zhang W; Zhu J; Zeng Y; Liu Z; Huang JA
    Cell Commun Signal; 2023 Nov; 21(1):311. PubMed ID: 37919739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
    Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
    Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells.
    Tsuruta N; Tsuchihashi K; Ohmura H; Yamaguchi K; Ito M; Ariyama H; Kusaba H; Akashi K; Baba E
    Biochem Biophys Res Commun; 2020 Sep; 530(1):235-239. PubMed ID: 32828292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms.
    Azzam SK; Alsafar H; Sajini AA
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA demethylation by FTO stabilizes the FOXJ1 mRNA for proper motile ciliogenesis.
    Kim H; Lee YS; Kim SM; Jang S; Choi H; Lee JW; Kim TD; Kim VN
    Dev Cell; 2021 Apr; 56(8):1118-1130.e6. PubMed ID: 33761320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer.
    Li Y; Zheng D; Wang F; Xu Y; Yu H; Zhang H
    Dig Dis Sci; 2019 Jun; 64(6):1503-1513. PubMed ID: 30637548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FTO demethylates YAP mRNA promoting oral squamous cell carcinoma tumorigenesis.
    Li DQ; Huang CC; Zhang G; Zhou LL
    Neoplasma; 2022 Jan; 69(1):71-79. PubMed ID: 34779644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FTO promotes the progression of retinoblastoma through YTHDF2-dependent N6-methyladenosine modification in E2F3.
    Xie W; Shao Y; Bo Q; Li Z; Yu Q; Wang L; Wu G
    Mol Carcinog; 2024 May; 63(5):926-937. PubMed ID: 38380957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
    Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
    J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.